Lardic, M. | IICIMED

Lardic, M.

Publications

P60

J. Enz. Inh. Med. Chem. 2008, 23(5), 728-738.

N-Pyridinyl(methyl)-indole-1- or 3-propanamides and propenamides acting as topical and systemic anti-inflammatory inhibitors.

Dassonville, A. | Lardic, M. | Breteche, A. | Nourrisson, M-R. | Le Baut, G. | Grimaud, N. | Petit, J-Y. | Duflos, M.

P56

Eur. J. Med. Chem., 2007, 42(5), 686-693.

Synthetic N-pyridinyl(methyl)-indol-3-ylpropanamides as new potential immunosuppressive agents.

Carbonnelle, D. | Lardic, M. | Dassonville, A. | Verron, E. | Petit, J-Y. | Duflos, M. | Lang, F.

P49

J. Enz. Inh. Med. Chem. 2006, 21, 313-325.

Synthesis and primary cytotoxicity evaluation of arylmethylenenaphthofuranone derivatives.

Lardic, M. | Patry, C. | Duflos, M. | Guillon, J. | Massip, S. | Cruzalegui, F. | Edmonds, T. | Giraudet, S. | Marini, L. | Leonce, S.

Autres publications scientifiques

Brevets

Thèse

T14.

Synthèse et évaluation pharmacologique de 3,6-diaryl-2,5-dihydroxy-1,4-benzoquinones et de 2 (ou 3)-arylméthylènenaphtofuran-3 (ou 2)-ones modulateurs de protéines kinases.

Lardic, M.

Nantes, 24 novembre 2004.